Antibiotics of limited use for most people with sore throats

March 2008
New Zealand Doctor;3/12/2008, p19
The article discusses the prescribing of antibiotics for patients with sore throats. Compared to placebo, antibiotics offer relative benefits in the treatment of sore throats. However, antibiotics also have a number of adverse effects. In modern western society, antibiotics are used to protect individuals with sore throats against complications.


Related Articles

  • Review: antibiotics are effective for acute purulent rhinitis but are associated with increased gastrointestinal side effects. Dorsen, Caroline // Evidence Based Nursing;Jan2007, Vol. 10 Issue 1, p9 

    The article reviews a study which examined the effectiveness of antibiotics for treating acute purulent rhinitis and its association with increased gastrointestinal side effects. Findings revealed the effectiveness of antibiotics compared to placebo. It stresses the importance of...

  • Antibiotics for Sore Throat. KOCHER, JARED J.; SELBY, THOMAS D. // American Family Physician;7/1/2014, Vol. 90 Issue 1, p23 

    The article discusses a study which examined the effectiveness of antibiotic therapy for sore throat. Topics discussed include the ability of antibiotics to shorten the duration of sore throat symptoms by about 16 hours, the likelihood of secondary outcomes such as headache, acute rheumatic...

  • Heparin.  // Reactions Weekly;Feb2015, Vol. 1540 Issue 1, p148 

    The article presents a case study of a patient who developed heparin thrombocytopenia (HIT) and complicating into bilateral adrenal haemorrhage, adrenal failure, and deep vein thrombosis.

  • Side effects. Mariotto, Aldo // British Journal of General Practice;Oct2014, Vol. 64 Issue 627, p524 

    The article offers information on a man who has suffered various side effects after being prescribed with antibiotics as treatment for his sore throat. It states that the man suffered heartburn that was treated using antacids which successively led to constipation. It adds that the man's...

  • Nesiritide and heart failure.  // Infectious Disease Alert;Sep2011 Clinical Bri, p2 

    The article reports on the results of a placebo-controlled randomized trial which indicated that nesiritide cannot be recommended for routine use of patients with congestive heart failure.

  • Should patients with severe sepsis receive drotrecogin alfa?  // Reactions Weekly;10/8/2005, Issue 1072, p5 

    Discusses research being done on the administration of drotrecogin alfa in early stage severe sepsis. Reference to a study by E. Abraham, P.-F. Laterre et al., published in the September 29, 2005 of the "New England Journal of Medicine"; Association of drotrecogin alfa use with higher rates of...

  • Long term donepezil did not delay institutionalisation or progression to disability in patients with Alzheimer's disease.  // Evidence Based Medicine;Feb2005, Vol. 10 Issue 1, p15 

    This article presents a clinical study which reports that long term donepezil did not delay institutionalisation or progression to disability in patients with Alzheimer's disease. Patients in the donepezil and placebo groups did not differ for rates of institutionalisation at 1 year or 3 years....

  • Nonspecific Medication Side Effects and the Nocebo Phenomenon. Barsky, Arthur J.; Saintfort, Ralph; Rogers, Malcolm P.; Borus, Jonathan F. // Science & Engineering Ethics;Jan2004, Vol. 10 Issue 1, p133 

    Patients taking active medications frequently manifest adverse, non-specific side effects that are not the direct result of the specific pharmacological action of the drug. Although this phenomenon is common, distressing and costly, it is rarely studied and poorly understood. The nocebo...

  • A Balancing Act: Microbe versus Muscle. Cosgrove, Sara E.; Corey, G. Ralph // Clinical Infectious Diseases;7/15/2009, Vol. 49 Issue 2, p181 

    The authors offer insights on the retrospective collection of data regarding drug-related adverse events in haphazard. They note that the treatment of serious drug-resistant gram-positive infections remains a challenge despite the development of several new antibiotics over the past 10 years. On...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics